Notably, in the recent 2021 WHO classification, only IDH wildtype GBM is considered as GBM, while the previously known IDH-mutant GBM is classified as IDH-mutant high-grade astrocytoma [70]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).